AstraZeneca has issued a warning to move vaccine manufacturing from the UK to the US due to supply chain issues, potentially impacting the UK’s vaccination efforts. The threat comes amid concerns over delays in vaccine deliveries and the EU’s export control measures, raising questions about the company’s commitment to fulfilling its UK contracts. The possible relocation could have significant repercussions on the UK’s vaccine distribution and production capabilities.
Source link
Loading PerspectiveSplit analysis...
